Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes / Thilo Deckersbach en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.1 (Enero)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.1 (Enero) . - pp. 100-108 Título : Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes : Results From the Bipolar CHOICE Study Tipo de documento: texto impreso Autores: Thilo Deckersbach, Autor ; Andrew A. Nierenberg, Autor ; Melvin G. McInnis, Autor Fecha de publicación: 2020 Artículo en la página: pp. 100-108 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicoticos, Trastorno bipolar - diagnóstico, Trastorno bipolar - psicología, Evaluación de discapacidad, Litio, Calidad de vida. Resumen: To examine the effects of treatment on functioning impairments and quality of life and assess baseline functioning and employment status as predictors of treatment response in symptomatic individuals from the Bipolar Clinical Health Outcomes Initiative in Comparative Effectiveness (Bipolar CHOICE) study. Link: ./index.php?lvl=notice_display&id=21703 [artículo] Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes : Results From the Bipolar CHOICE Study [texto impreso] / Thilo Deckersbach, Autor ; Andrew A. Nierenberg, Autor ; Melvin G. McInnis, Autor . - 2020 . - pp. 100-108. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.1 (Enero) . - pp. 100-108 Palabras clave: Antipsicoticos, Trastorno bipolar - diagnóstico, Trastorno bipolar - psicología, Evaluación de discapacidad, Litio, Calidad de vida. Resumen: To examine the effects of treatment on functioning impairments and quality of life and assess baseline functioning and employment status as predictors of treatment response in symptomatic individuals from the Bipolar Clinical Health Outcomes Initiative in Comparative Effectiveness (Bipolar CHOICE) study. Link: ./index.php?lvl=notice_display&id=21703

Cognitive-behavioral therapy for depression. Applications and outcome / Thilo Deckersbach en Psychiatric Clinics of North America, Año 2000- Vol. 23 No. 4 (Diciembre)

Público ISBD [artículo]  inPsychiatric Clinics of North America > Año 2000- Vol. 23 No. 4 (Diciembre) . - pp. 795-809 Título : Cognitive-behavioral therapy for depression. Applications and outcome Tipo de documento: texto impreso Autores: Thilo Deckersbach, Autor ; Beth S. Gershuny, Autor ; Michael W. Otto, Autor Fecha de publicación: 2020 Artículo en la página: pp. 795-809 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Terapia cognitiva conductual, Trastorno depresivo mayor. Resumen: Patients with major depression have a choice between several empirically supported therapies, including pharmacotherapy, cognitivebehavior therapy (CBT), and interpersonal therapy (IPT). This article reviews the application and outcome of CBT for major depression. Link: ./index.php?lvl=notice_display&id=24910 [artículo] Cognitive-behavioral therapy for depression. Applications and outcome [texto impreso] / Thilo Deckersbach, Autor ; Beth S. Gershuny, Autor ; Michael W. Otto, Autor . - 2020 . - pp. 795-809. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Psychiatric Clinics of North America > Año 2000- Vol. 23 No. 4 (Diciembre) . - pp. 795-809 Palabras clave: Terapia cognitiva conductual, Trastorno depresivo mayor. Resumen: Patients with major depression have a choice between several empirically supported therapies, including pharmacotherapy, cognitivebehavior therapy (CBT), and interpersonal therapy (IPT). This article reviews the application and outcome of CBT for major depression. Link: ./index.php?lvl=notice_display&id=24910

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia / A. Eden Evins en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 218-225 Título : A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia Tipo de documento: texto impreso Autores: A. Eden Evins, Autor ; Corinne Cather, Autor ; Thilo Deckersbach, Autor Fecha de publicación: 2023 Artículo en la página: pp. 218-225 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Bupropión, Esquizofrenia, Tabaquismo, Fumar - metabolismo, Tabaquismo - psicología Resumen: The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropion sustained-release 300 mg/d or identical placebo. Link: ./index.php?lvl=notice_display&id=30905 [artículo] A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia [texto impreso] / A. Eden Evins, Autor ; Corinne Cather, Autor ; Thilo Deckersbach, Autor . - 2023 . - pp. 218-225. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 218-225 Palabras clave: Bupropión, Esquizofrenia, Tabaquismo, Fumar - metabolismo, Tabaquismo - psicología Resumen: The objective of this study was to examine the efficacy of bupropion for smoking cessation in patients with schizophrenia. Adults with schizophrenia who smoked more than 10 cigarettes per day and wished to try to quit smoking were recruited from community mental health centers, enrolled in a 12-week group cognitive behavioral therapy intervention, and randomly assigned to receive either bupropion sustained-release 300 mg/d or identical placebo. Link: ./index.php?lvl=notice_display&id=30905

---

1 (1 - 3 / 3)